Goldman Sachs ActiveBeta ... (GSSC)
NYSEArca: GSSC
· Echtzeitkurs · USD
92.37
+0.35 (0.38%)
Zum Schluss: Aug 13, 2026, 3:59 PM
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) ETF Price, Holdings & Analysis
0.38% (1D)
| Geld | 87.24 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 1.06 Mrd |
| NAV | 92.00 |
| Beta | 1.14 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 17.18 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Jun 28, 2017 |
| Brief | 97.78 |
| Volumen | 12,908 |
| Ø Vol. (20D) | 35,417 |
| Eröffnung | 92.47 |
| Vortagesschluss | 92.02 |
| Tagesspanne | 92.20 - 92.75 |
| 52-Wk Range | 70.21 - 92.84 |
| Positionen | k.A. |
| Kostenquote | 0.20% |
Über GSSC
The fund seeks to achieve its investment objective by investing at least 80% of its assets in securities included in its index, in depositary receipts representing securities included in the index and in underlying stocks in respect of depositary receipts included in its index. The index is designed to deliver exposure to equity securities of small capitalization U.S. issuers.
Anlageklasse Equity
Tickersymbol GSSC
Auflagedatum Jun 28, 2017
Anbieter Goldman Sachs
Website Fonds-Homepage
Börse NYSEArca
Top Sektoren
| Sektor | Gewicht % |
|---|---|
| Healthcare | 20.75% |
| Financial Services | 17.88% |
| Technology | 14.54% |
| Industrials | 12.72% |
| Consumer Cyclical | 10.56% |
Top 10 Positionen 3.78% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Goldman Sachs Fs Tre... | FTOXX | 0.98% |
| Enova International ... | ENVA | 0.42% |
| Alkermes PLC | ALKS | 0.39% |
| 10x Genomics Inc Ord... | TXG | 0.37% |
| Caredx Inc | CDNA | 0.35% |
| Stonex Group Inc | SNEX | 0.33% |
| Travere Therapeutics... | TVTX | 0.32% |
| Acadian Asset Manage... | AAMI | 0.31% |
| Dave Inc Ordinary Sh... | DAVE | 0.31% |
Dividenden Dividendenrendite 1.01%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Jun 24, 2026 | $0.2140 | k.A. |
| Mar 25, 2026 | $0.2050 | k.A. |
| Dec 23, 2025 | $0.2470 | k.A. |
| Sep 24, 2025 | $0.2710 | k.A. |
| Jun 24, 2025 | $0.1940 | k.A. |
